Front. Pharmacol.Frontiers in PharmacologyFront. Pharmacol.1663-9812Frontiers Media S.A.137459510.3389/fphar.2024.1374595PharmacologyCorrectionCorrigendum: Cardioprotective effect of Sanguisorba minor against isoprenaline-induced myocardial infarction in ratsHosseini et al.10.3389/fphar.2024.1374595HosseiniAzar12GhorbaniAtieh3Sadat AlaviMohaddeseh2ForouhiNima1RajabianArezoo4Boroumand-NoughabiSamaneh5SahebkarAmirhossein67*EidAli H.8*1Department of Pharmacology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran2Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran3Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran4Department of Internal Medicine, Faculty of Medicine, Mashhad University of Medical Science, Mashhad, Iran5Department of Pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran6Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran7Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran8Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, Doha, Qatar
Edited and reviewed by:Syed Shams Ul Hassan, Shanghai Jiao Tong University, China
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
A Corrigendum on Cardioprotective effect of Sanguisorba minor against isoprenaline-induced myocardial infarction in rats by Hosseini A, Ghorbani A, Alavi MS, Forouhi N, Rajabian A, Boroumand-Noughabi S, Sahebkar A and Eid AH (2023). Front. Pharmacol. 14:1305816. doi: 10.3389/fphar.2023.1305816myocardial infarctionisoprenalineoxidative stresscardiotoxicityherbal medicinesuperoxide dismutasesection-at-acceptanceExperimental Pharmacology and Drug Discovery
In the published article, there was an error in Figure 4A as published. During the last stage of revision, labels in Figure 4A were inadvertently altered, and the group labels in the figure were mistakenly substituted. The corrected Figure 4A appears below:
Effect of S. minor on the levels of cTn-T, CK-MB, LDH, and CPK after isoproterenol administration. The levels of cTn-T (A), CK-MB (C), CPK (B), and LDH (D) were evaluated in serum. Data were expressed as mean ± SEM. ###p < 0.001 in comparison with the control group. ***p < 0.001 in comparison with isoprenaline (85 mg/kg).
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.